← Back to Search

Dietary Supplement

Creatine monohydrate for Endothelial Dysfunction

N/A
Waitlist Available
Led By Holly E Clarke, MS
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
both male and female
50-64 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and week 4
Awards & highlights

Study Summary

This trial looks at the effects of taking creatine for 4 weeks on various measures of physical and cognitive performance, as well as markers of micro- and macrovascular function.

Eligible Conditions
  • Endothelial Dysfunction
  • Stress Oxidative

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and week 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in augmentation (AUG) and augmentation index (AIx) using pulse wave analysis (PWA) at week 4
Structure of brachial artery
Change from baseline in brachial-ankle pulse wave velocity (baPWV) at week 4
+8 more
Secondary outcome measures
Change from baseline in body fat mass (grams) at week 4
Change from baseline in body fat percent (BF%) at week 4
Change from baseline in body lean mass (grams) at week 4
+3 more

Side effects data

From 2015 Phase 4 trial • 14 Patients • NCT01514630
71%
Cold and flu symptoms
29%
Diarrhea
21%
Stomach Discomfort
14%
Muscle Cramps
7%
Lightheaded
7%
Headache
7%
Nausea
7%
Indigestion
7%
Polydipsia
7%
Swelling in Hands
7%
Numbness and Tingling in hands
100%
80%
60%
40%
20%
0%
Study treatment Arm
Creatine Monohydrate

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Creatine monohydrateExperimental Treatment1 Intervention
Participants received 4 x 5g doses of creatine monohydrate (powdered form) for 5 days, followed by 1 x 5g doses of creatine monohydrate (powdered form) for 23 days.
Group II: PlaceboPlacebo Group1 Intervention
Participants received 4 x 5g doses of placebo (powdered Maltodextrin) for 5 days, followed by 1 x 5g doses of placebo (powdered Maltodextrin) for 23 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Creatine monohydrate
2005
Completed Phase 4
~620

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
197 Previous Clinical Trials
30,628 Total Patients Enrolled
2 Trials studying Endothelial Dysfunction
35 Patients Enrolled for Endothelial Dysfunction
Holly E Clarke, MSPrincipal InvestigatorFlorida State University
Holly E Clarke, PhDPrincipal InvestigatorFlorida State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Mar 2025